MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2022-23)
- Udyam number
- UDYAM-TS-02-0003927
Nasense Labs Private Limited - chemicals and materials in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹135.51 Cr
▲ 17% YoY
Net profit · FY 2025
₹5.7 Cr
Net margin 4.2%
EBITDA · FY 2025
₹18.64 Cr
EBITDA margin 13.8%
Authorised capital
₹24 Cr
Registered with MCA
Paid-up capital
₹23.57 Cr
Issued & subscribed
Open charges
₹78.17 Cr
Satisfied ₹54.65 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
81
Provident fund records
About Nasense Labs Private Limited
Data last updated:
Nasense Labs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 24 March 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24231TG1995PTC019809. Its GSTIN is 36AAACU6806D1ZJ (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹24 Cr and a paid-up capital of ₹23.57 Cr. It was formerly known as Usp Organics Private Limited and Usp Scientifics Private Limited. It is led by directors including Goutam Gottumukkala (Managing Director) and Arjun Gottumukkala.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot Nos. 24 & 25 S. V. Co – Operative Indl Estate Jeedimetla Quthubullapur (M), Hyderabad, Telangana, India – 500055.
As per the financials filed for FY 2025, the company reported a revenue of ₹135.51 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹5.7 Cr (net margin 4.2%) and EBITDA of ₹18.64 Cr (EBITDA margin 13.8%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years.
The company has about 81 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Nasense Labs. As per MCA filings, the company has open charges of ₹78.17 Cr and satisfied charges of ₹54.65 Cr on record. Court records list 34 cases involving the company, including 2 filed by the company and 32 filed against it; 1 case is pending. The company has 6 deals on record (3 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹18.98 Cr; the latest was in August 2021. Its 10 peer companies in the Chemicals industry (Specialty Chemicals) are compared by revenue, 5 larger and 5 smaller; the largest is Prolife Bio-Chemical Industries Private Limited with revenue of ₹141.84 Cr.
Nasense Labs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0003927). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nasense.com.
Company Details of Nasense Labs Private Limited
CIN U24231TG1995PTC019809
Registration Number 019809
Incorporation Date 24 March 1995
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-02-0003927
Name History of Nasense Labs Private Limited
Nasense Labs has undergone 2 name changes throughout its history. The company was previously known as Usp Organics Private Limited, and Usp Scientifics Private Limited. The current legal name is Nasense Labs Private Limited.
| Company Name | Status |
|---|---|
| Nasense Labs Private Limited | Current |
| Usp Organics Private Limited | Previous |
| Usp Scientifics Private Limited | Previous |
CIN History of Nasense Labs Private Limited
Nasense Labs has one previous CIN (Corporate Identification Number): U24231AP1995PTC019809. The current CIN is U24231TG1995PTC019809, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231TG1995PTC019809 | Current |
| U24231AP1995PTC019809 | Previous |
Key People
Goutam Gottumukkala Managing Director Prasad Jakkaraju Nominee Director Arjun Gottumukkala Director Recognitions & Rankings of Nasense Labs
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot Nos. 24 & 25 S. V. Co – Operative Indl Estate Jeedimetla Quthubullapur (M), Hyderabad, Telangana, India – 500055
- IndustryChemicals and Materials, Specialty Chemicals
Comprehensive company report
Nasense Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Nasense Labs Private Limited
Nasense Labs operates one associated brand: Nasense Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures fine chemicals, pyridine derivatives, and pharmaceutical intermediates for industries. | nasense.com |
Business Activity of Nasense Labs Private Limited
The main business activity of Nasense Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nasense Labs Private Limited FY 2024 filings available
Nasense Labs Private Limited reported revenue of ₹135.51 Cr (up 17% YoY) for FY 2025.
Revenue · FY 2025
₹135.51 Cr ▲ 17%
Net profit · FY 2025
₹5.7 Cr margin 4.2%
EBITDA · FY 2025
₹18.64 Cr margin 13.8%
Compounded Annual Growth Rate (CAGR) of Nasense Labs Private Limited
Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▲ 51%
3 years · compounded
▲ 95%
5 years · compounded
▲ 5%
Revenue has grown at a compounded annual rate (CAGR) of 2% over three years, including 17% growth in the latest year. EBITDA rose 51% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nasense Labs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹18.64 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.7 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nasense Labs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nasense Labs are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Nasense Labs Private Limited
Nasense Labs has 4 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prasad Jakkaraju Also directs: Nacl Spec-Chem Limited | Nominee Director | 15 Feb 2022 | 4 Years 8 Months | Current |
| Arjun Gottumukkala | Director | 30 Sep 2022 | 4 Years 0 Months | Current |
| Goutam Gottumukkala | Managing Director | 02 Apr 2009 | 17 Years 6 Months | Current |
| Venkata Satya Samba Siva Rao Mantripragada Also directs: KLR Products Limited | Nominee Director | 15 Feb 2022 | 4 Years 8 Months | Current |
Peer Comparison of Nasense Labs Private Limited
Nasense Labs Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (Specialty Chemicals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Prolife Bio-Chemical Industries Private Limited | ₹141.84 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Ahmedabad, Gujarat, India |
| Ambuja Solvex Private Limited | ₹140.27 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Ahmedabad, Gujarat, India |
| Imerys Vizag Private Limited | ₹138.49 Cr (FY 2025) | •••• | •••• | 44.0% | •••• | Anakapalle, Andhra Pradesh, India |
| Corvine Chemicals and Pharmaceuticals Private Limited | ₹136.26 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Bidar, Karnataka, India |
| Mody Chemi Pharma Limited | ₹136.07 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Mumbai, Maharashtra, India |
| Nasense Labs Private Limited this company | ₹135.51 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Hyderabad, Telangana, India |
| Katra Phytochem (India) Private Limited | ₹134.65 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | Bangalore, Karnataka, India |
| Melog Speciality Chemicals Private Limited | ₹134.59 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Mumbai, Maharashtra, India |
| Chemfield Cellulose Private Limited | ₹134.22 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Nagpur, Maharashtra, India |
| Surabhi Industries (India) Private Limited | ₹133.75 Cr (FY 2024) | •••• | •••• | -37.0% | •••• | Hyderabad, Telangana, India |
| Navdeep Chemicals Private Limited | ₹133.57 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Nasense Labs by revenue in the Chemicals industry (Specialty Chemicals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nasense Labs Private Limited
Nasense Labs Private Limited is audited by K.R.BAPUJI & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K.R.BAPUJI & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Nasense Labs Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nasense Labs Private Limited
Open charges
₹78.17 Cr
Satisfied charges
₹54.65 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Mar 2025 | Others | ₹6.38 Cr | Open |
| 28 Nov 2020 | Others | ₹5.57 Cr | Open |
| 13 Jun 2015 | Others | ₹66.22 Cr | Open |
| 19 Sep 2020 | Others | ₹1.91 Cr | Satisfied |
| 07 May 2020 | Others | ₹2.6 Cr | Satisfied |
Total charge records: 14 View all charges
Deals & Funding of Nasense Labs Private Limited
Nasense Labs Private Limited has 6 deals on record (3 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹18.98 Cr; the latest was in August 2021.
Total deals
6
Funding rounds
3
Secondary share transfers
2
Rights issue
1
Disclosed funding
₹18.98 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2021 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Jun 2021 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Jun 2018 | Rights issue | ₹12.37 Cr | Investors: Nacl Industries Limited , 3 individuals |
| Oct 2013 | Funding round | ₹5.52 Cr | Investors: Nacl Industries Limited , 3 individuals |
| Oct 2010 | Funding round | ₹7.02 Cr | Investors: Nacl Industries Limited , 3 individuals |
Premium access
Full deal history
All 6 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Nasense Labs Private Limited
Nasense Labs Private Limited has 34 court cases on record: 2 filed by Nasense Labs, 32 filed against it. 1 case is pending and 33 are disposed.
Total cases
34
Filed by the company
2
Filed against the company
32
Pending
1
Disposed
33
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 31 | 31 | 0 |
| High courts | 3 | 1 | 1 |
Cases on record (5 of 34)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed against the company by Resonance Specialties Ltd Through Authorized Representative Vaibhavi Rajeshirke | Disposed |
| District court, Medchal Malkajgiri, Telangana | Execution petition | Filed against the company by M/S India Infoline Finance Ltd Rep. by Jeevan Kumar Dosala | Disposed |
| District court, Hyderabad Central, Telangana | Court case (STC - NI) | Filed against the company by M/S. Reliance Commercial Finance Ltd, Rep by Its Deputy Manager Javed Hussain | Disposed |
| High Court, TAMIL NADU | Court case (CRL OP) | Filed by the company against Balmer Lawrie and Co.Ltd., Rep and 2 others | Disposed |
| District court, Hyderabad Central, Telangana | Criminal complaint | Filed against the company by M/S Bajaj Finance Limited., Rep.By M. Ravind | Disposed |
Premium access
Full case history
All 34 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Nasense Labs Private Limited
Nasense Labs Private Limited has a workforce of 81 employees as of Mar 27, 2024.
Employee count
81
Active EPFO establishments
1
Employee growth
-3.57%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Nasense Labs Private Limited
Nasense Labs has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Associated companies
Recent Activity on Nasense Labs Private Limited
Nasense Labs Private Limited has 14 board changes on record since 2007: 4 appointments and 10 cessations. The latest: Arjun Gottumukkala was appointed as Director on 30 Sep 2022.
Charges
A charge with Others amounted to Rs. 6.38 Cr with Charge ID 101084502 was registered on 07 Mar 2025.
AGM
Nasense Labs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Nasense Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Others of Rs. 66.22 Cr registered on 13 Jun 2015 with Charge ID 10587845 was modified on 22 Jun 2023.
Charges
A charge registered on 27 Jun 2016 via Charge ID 100037567 with Others was fully satisfied on 30 Nov 2022.
Appointed
Arjun Gottumukkala was appointed as Director.
Ceased
Uma Gottumukkala ceased to be Whole-Time Director.
Charges
A charge registered on 19 Sep 2020 via Charge ID 100385732 with Others was fully satisfied on 22 Jul 2022.
Charges
A charge registered on 07 May 2020 via Charge ID 100386535 with Others was fully satisfied on 22 Jul 2022.
Charges
A charge registered on 18 Sep 2018 via Charge ID 100205467 with Others was fully satisfied on 12 Jul 2022.
Charges
A charge registered on 01 Jan 2018 via Charge ID 100150030 with Others was fully satisfied on 12 Jul 2022.
Charges
A charge registered on 24 Jul 2017 via Charge ID 100115446 with Others was fully satisfied on 12 Jul 2022.
32 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Nasense Labs Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nasense Labs Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nasense Labs Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nasense Labs Private Limited
Nasense Labs has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACU6806D1ZJ | Telangana | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nasense Labs Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Nasense Labs Private Limited
Frequently Asked Questions about Nasense Labs Private Limited
Nasense Labs is an active private limited company based in Hyderabad, Telangana, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 24 March 1995 (31+ years old) and is registered under CIN U24231TG1995PTC019809.
Nasense Labs reported revenue of ₹135.51 Cr for FY 2025 (up 17% YoY).
Nasense Labs has 4 current directors:
- Goutam Gottumukkala - Managing Director
- Prasad Jakkaraju - Nominee Director
- Arjun Gottumukkala - Director
- Venkata Satya Samba Siva Rao Mantripragada - Nominee Director
Nasense Labs reported a net profit of ₹5.7 Cr (net margin 4.2%) and EBITDA of ₹18.64 Cr (EBITDA margin 13.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nasense Labs is 2% over three years. In the latest year (FY 2025) revenue rose 17%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nasense Labs is 36AAACU6806D1ZJ, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Nasense Labs is U24231TG1995PTC019809. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nasense Labs has 34 court cases on record: 2 filed by the company and 32 filed against it. 1 is pending. Most are in the district courts.
Nasense Labs was incorporated on 24 March 1995, making it 31+ years old. It is registered with the Registrar of Companies, Hyderabad.
Nasense Labs has 6 deals on record (3 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹18.98 Cr; the latest was in August 2021.
The peers of Nasense Labs by revenue are Prolife Bio-Chemical Industries Private Limited, Ambuja Solvex Private Limited, Imerys Vizag Private Limited, Corvine Chemicals and Pharmaceuticals Private Limited, Mody Chemi Pharma Limited and 5 more, all in the Chemicals industry (Specialty Chemicals).